Asia-Pacific Safety Syringes Market Overview
There has been a constant demand to safeguard health care workers from accidental needle-stick injuries and healthcare-acquired infections. Safety syringes are specifically designed to meet this need.
With the rise in the incidence of needlestick injuries, new initiatives and legislation by governments to incorporate the practice of safety syringes, favorable reimbursement policies, and upgraded safety mechanisms for syringes are boosting the growth of Asia-Pacific safety syringes market. At present, quite a few countries have enforced regulations to ensure the compulsory use of safety syringes with an intention of preventing needle stick injuries and confine needle re-use. These regulations are expected to increase the common usage of safety syringes as compared to conventional syringes. However, availability of alternate drug delivery methods, the high price of safety syringes and their ignorance in developing countries due to lack of proper awareness about healthcare and safety issues are few factors off-putting the growth of Asia-Pacific safety syringes market.
Asia-Pacific Safety Syringes Market Forecast Report (2018-2023)
Asia-Pacific Safety Syringes Market is estimated at USD 880 million in 2018 and is predicted to reach USD 1470 million by 2023, growing at a CAGR of 10.92%.
Asia-Pacific Safety Syringes Industry Segment Analysis
The Asia-Pacific safety syringes market can be categorized on the basis of technology into Retractable and Non-Retractable safety syringes. The retractable syringes market is sub-segmented into Automatic or Manual syringes. And the non-retractable safety syringes are sub-segmented into sliding needle cover syringes, sheathing tube syringes, and hinged needle cover syringes. Non-retractable safety syringes hold the major share of sales in the Asia-Pacific regions while the retractable safety syringes segment is anticipated to rise at a higher CAGR within the forecast period. Furthermore, on the basis of therapy, the safety syringes market can be categorized under Insulin, Tuberculosis, Glucagon-like peptide-1 (GLP-1) and Growth Hormones. Moreover, taking into account end users, the Asia-Pacific safety syringe market is branded under hospitals and home care segments.
Asia-Pacific Safety Syringes Market Forecast Report (2018-2023)
Geographically, the Asia-Pacific safety syringe market is segmented and analyzed various regions namely India, China, Japan, South Korea, and Australia. Asia-Pacific region is expected to register the highest growth rate within the forecast period. The market in this region is currently experiencing a paradigm shift in usage of safety syringes over conventional ones.
Major Key Players
Some of the major companies operating in the Asia-Pacific safety syringes market
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Technology
5.1.1 Retractable safety syringes
5.1.1.1 Automatic retractable safety syringes
5.1.1.2 Manual retractable safety syringes
5.1.2 Non-Retractable safety syringes
5.1.2.1 Sheathing tube syringes
5.1.2.2 Sliding needle cover syringes
5.1.2.3 Hinged needle cover syringes
5.2 By Therapy
5.2.1 Insulin
5.2.2 Glucagon-like peptide-1 (glp-1)
5.2.3 Tuberculosis
5.2.4 Growth hormones
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Care
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton, Dickinson & Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Covidien plc
8.3 Revolutions Medical Corporation
8.4 Retractable Technologies, Inc.
8.5 Smiths Medical
8.6 Unilife Corporation
8.7 Terumo Corporation
8.8 Sol-Millennum
8.9 Ultimed, Inc.
8.10 Axel Bio Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
